Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 3 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.
Br J Cancer. 2024 Jan;130(1):151-162. doi: 10.1038/s41416-023-02484-8. Epub 2023 Nov 15.
Br J Cancer. 2024.
PMID: 37968472
BET protein-dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer.
Morino S, Mashima T, Shirai F, Nagayama S, Katayama R, Seimiya H.
Morino S, et al.
Cancer Lett. 2024 Mar 1;584:216632. doi: 10.1016/j.canlet.2024.216632. Epub 2024 Jan 11.
Cancer Lett. 2024.
PMID: 38216082
Item in Clipboard
Pharmacological targeting of histone H3K27 acetylation/BRD4-dependent induction of ALDH1A3 for early-phase drug tolerance of gastric cancer.
Lee J, Mashima T, Kawata N, Yamamoto N, Morino S, Inaba S, Nakamura A, Kumagai K, Wakatsuki T, Takeuchi K, Yamaguchi K, Seimiya H.
Lee J, et al. Among authors: morino s.
Cancer Res Commun. 2024 Apr 25. doi: 10.1158/2767-9764.CRC-23-0639. Online ahead of print.
Cancer Res Commun. 2024.
PMID: 38669046
Free article.
Item in Clipboard
Cite
Cite